Skip to main content

Table 2 Frequency of adverse events

From: Tolerability and safety of urotainer® polihexanide 0.02% in catheterized patients: a prospective cohort study

 

N = 32

Not related

Related

Mild

Moderate

Severe

Mild

Moderate

Severe

n (%)

n (%)

n (%)

n (%)

n (%)

n (%)

Abdominal pain

1 (3.1)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

Diarrhoea

1 (3.1)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

Pain

0 (0.0)

0 (0.0)

0 (0.0)

1 (3.1)

0 (0.0)

0 (0.0)

Pyrexia

0 (0.0)

1 (3.1)

0 (0.0)

1 (3.1)

0 (0.0)

0 (0.0)

Urinary tract infection

0 (0.0)

0 (0.0)

0 (0.0)

1 (3.1)

0 (0.0)

0 (0.0)

Fall

1 (3.1)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

Muscle spasms

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

2 (6.3)

0 (0.0)

Bladder discomfort

0 (0.0)

0 (0.0)

0 (0.0)

1 (3.1)

0 (0.0)

0 (0.0)

Bladder irritation

0 (0.0)

0 (0.0)

0 (0.0)

1 (3.1)

0 (0.0)

0 (0.0)

Bladder pain

0 (0.0)

0 (0.0)

0 (0.0)

2 (6.3)

2 (6.3)

0 (0.0)

Bladder spasm

0 (0.0)

0 (0.0)

0 (0.0)

6 (18.8)

3 (9.4)

0 (0.0)

Urethral pain

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

1 (3.1)

0 (0.0)

Urinary incontinence

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

1 (3.1)

0 (0.0)

Cough

0 (0.0)

1 (3.1)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

Hypertension

1 (3.1)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)